Skip to main content
SpringerLink
Log in

Pharmacokinetics of human growth hormone releasing factor (hGRF-44 NH2) in normal men after intravenous administration of a large range of doses

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

Three ranges of doses of growth hormone releasing factor (2.5–80 µg, 80–320 µg and 75–600 µg) were intravenously administered to healthy young volunteers in three double blind studies.

Serum circulating GRF levels were determined by radioimmunoassay. Experimental concentration curves were fitted, using the extended least squares method, to a biexponential model for the structural model and power function for the variance model.

The power variance model, compared to the constant variance model greatly reduced the coefficient of variation of the biexponential parameters. The power of the variance model was estimated to be 1.95. The distribution half-life was 6.6 min and the elimination half-life was 39.0 min (harmonic means). Total clearance was 0.12±0.01 µg/l/min.

No difference between these parameters was found for the various doses. GRF kinetics was linear established in the range 10 to 600 µg which means that elimination was not altered by the increased doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Guillemin R, Brazeau P, Böhlen P, Esch F, Ling N, Wehrenberg WB (1982) Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly. Science 218: 585–588

    Google Scholar 

  2. Sassolas G, Chayvialle JA, Partensky C, Berger G, Trouillas J, Berger F, Claustrat B, Cohen R, Girod C, Guillemin R (1983) Acromégalie, expression clinique de la production de facteurs de libération de l'hormone de croissance (GRF) par une tumeur pancréatique. Ann Endocrinol 44: 347–351

    Google Scholar 

  3. Rivier J, Spiess J, Thorner M, Vale W (1982) Characterization of a growth hormone-releasing factor from a human pancreatic islet tumor. Nature 300: 276–278

    Google Scholar 

  4. Thorner MO, Perryman RL, Cronin MJ, Rogol AD, Draznin M, Johanson A, Vale W, Horvath E, Kovacs K (1982) Somatotroph hyperplasia. Successful treatment of acromegaly by removal of a pancreatic islet tumor secreting a growth hormone-releasing factor. J Clin Invest 82: 965–970

    Google Scholar 

  5. Ling N, Esch F, Böhlen P, Brazeau P, Wehrenberg WB, Guillemin R (1984) Isolation, primary structure and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor. Proc Natl Acad Sci USA 81: 4302–4307

    Google Scholar 

  6. Wehrenberg WB, Ling N, Brazeau P, Esch F, Böhlen P, Baird A, Ying S, Guillemin R (1982) Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats. Biochem Biophys Res Commun 109: 382–387

    Google Scholar 

  7. Wehrenberg WB, Ling N, Böhlen P, Esch F, Brazeau P, Guillemin R (1982) Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion. Biochem Biophys Res Commun 109: 562–567

    Google Scholar 

  8. Thorner MO, Rivier J, Spiess J, Borges JL, Vance ML, Bloom SR, Rogol AD, Cronin MJ, Keiser DL, Evans WS, Webster JD, Macleod RM, Vale W (1983) Human pancreatic growth hormone releasing factor selectively stimulates growth hormone secretion in man. Lancet 1: 24–28

    Google Scholar 

  9. Vance ML, Borges JLC, Keiser DL, Evans WS, Furlanetto R, Thominet JL, Frohman LA, Rogol AD, Macleod RM, Bloom S, Rivier J, Vale W, Thorner MO (1984) Human pancreatic tumor growth hormone-releasing factor: dose-response relationships in normal man. J Clin Endocrinol Metab 58: 838–844

    Google Scholar 

  10. Gelato MC, Pescovitz OH, Cassorla F, Loriaux DL, Merriam GR (1984) Dose-response relationships for the effects of growth hormone-releasing factor (1–44) NH2 in young adult men and women. J Clin Endocrinol Metab 59: 197–201

    Google Scholar 

  11. Sassolas G, Chatelain P, Cohen R, Boissel JP, Laporte S, Galleyrand J, Claustrat B, Elmcharfi A, Chayvialle JA, Cohen H, Ferry S, Underwood L (1984) Effects of human pancreatic tumor growth hormone-releasing hormone (hpGRF1-1-44-NH2) on immunoreactive and bioactive plasma growth hormone in normal young men. J Clin Endocrinol Metab 59: 705–709

    Google Scholar 

  12. Rosenthal SM, Schriock EA, Kaplan SL, Guillemin R, Grumbach MM (1983) Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men. J Clin Endocrinol Metab 57: 677–679

    Google Scholar 

  13. Boissel JP, Cohen R, Biot-Laporte S, Claustrat B, Renard H, Olivier M, Sassolas G (1986) Synthetic human growth hormone releasing factor effect (hGRF-I44-NH2) dose response on growth hormone and prolactin secretion in healthy adult men. Eur J Clin Pharmacol 29: 609–614

    Google Scholar 

  14. Sassolas G, Biot-Laporte S, Cohen R, Chatelain P, Boissel JP, Ferry S, Chayvialle JA, Duprou P, Claustrat B, Girard P, Boisou F, Trouillas P, Lores B (1986) Clinical studies with human growth hormone releasing factor in normal adults and proticute. Peptides 7 [Suppl 1]: 281–286

    Google Scholar 

  15. Guillemin R, Ling N, Vargo T (1977) Radioimmunoassays for — endorphin and -endorphin. Biochem Biophys Res Commun 73: 361

    Google Scholar 

  16. Greenwood FC, Hunter WM, Glover JS (1963) The preparation of131I-labelled human growth hormone of high specific radioactivity. Biochem J 89: 114

    Google Scholar 

  17. Frohman LA, Thominet JL, Webb CB, Vance ML, Uderman H, Rivier J, Vale W, Thorner MO (1984) Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. J Clin Invest 73: 1304–1311

    Google Scholar 

  18. Rowland M, Tucker G (1980) Symbols in pharmacokinetics. J Pharmacol Biopharmacol 8: 497–507

    Google Scholar 

  19. Von Hattingber HM, Brockmeier D, Kreuter G (1977) A rotating iterative procedure (RIP) for estimating hybrid constants in multicompartment analysis on desk-computers. Eur J Clin Pharmacol 11: 381–388

    Google Scholar 

  20. Sheiner LB (1985) A program for the extended least squares fit. Users manual. University of California, Division of Clinical Pharmacology, San Francisco, California

    Google Scholar 

  21. Armittage P (1977) Statistical methods in medical research. Blackwell, Oxford, pp 269–301

    Google Scholar 

  22. Finney DJ (1979) Statistical computation for immunoassay. In: Wilson DW, Gaskell SJ, Kemp KW (ed) Quality control in clinical endocrinology. Alpha Omega Publishing Ltd, Cardiff

    Google Scholar 

  23. Peck CC, Sheiner LB, Nichols AI (1984) The problem of choosing weights in non-linear regression analysis of pharmacokinetic data. Drug Metab Rev 15: 133–148

    Google Scholar 

  24. Peck CC, Beal SL, Sheiner LB, Nichols AI (1984) Extended least squares non linear regression: a possible solution to the choice of weights problem in analysis of individual pharmacokinetic data. J Pharm Biopharm 12: 545–558

    Google Scholar 

  25. Thompson AH, Kelman AW, Whiting B (1985) Evaluation of nonlinear regression with extended least squares: simulation study. J Pharm Sci 74/12: 1327–1330

    Google Scholar 

  26. Sassolas G, Garry J, Cohen R, Bastuji H, Vermeulen E, Cabrera P, Roussel B, Jouvet M (1986) Noctural continuous infusion of growth hormone releasing hormone results in a dose-dependent accentuation of episodic growth hormone secretion in normal men. J Clin Endocrinol Metab 63/4: 1016–1022

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Unité de Pharmacologie Clinique, Hôpital Neuro-Cardiologique, Lyon, France

    P. Girard & J. P. Boissel

  2. Service de Radioanalyse, Lyon, France

    R. Cohen, C. Harthe & P. Cabrera

  3. Unité de Soins, Centre de Médecine Nucléaire, Lyon, France

    G. Sassolas

Authors
  1. P. Girard
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Sassolas
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Harthe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Cabrera
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. P. Boissel
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Girard, P., Cohen, R., Sassolas, G. et al. Pharmacokinetics of human growth hormone releasing factor (hGRF-44 NH2) in normal men after intravenous administration of a large range of doses. Eur J Clin Pharmacol 32, 507–513 (1987). https://doi.org/10.1007/BF00637679

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00637679

Key words

Search

Navigation